1. Targeted Mobilisation of Endogenous Endothelial Progenitor Cells — an Alternate Approach to Allogeneic Therapy for Ischaemic Cardiovasular Disease?

   • Karla M. O’Neill
   • David J. Grieve

   Invited Editorial 03 May 2023 Pages: 839 - 841

2. Trimetazidine to Reduce Myocardial Fibrosis—Competing Interests with SGLT2 Inhibitors?

   • Tyler B. Moran
   • Masafumi Kitakaze
   • Yochai Birnbaum

   Editorial 13 September 2023 Pages: 843 - 844

3. Reply to the Letter to the Editor Titled “The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?” by Han et al

   • Senay Akin
   • Haydar A. Demirel

   Letter to the Editor 20 August 2022 Pages: 845 - 846

4. The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?

   • Qian-Feng Han
   • Jia-Hui Liu
   • De-Gang Mo

   Letter to the Editor 24 August 2022 Pages: 847 - 848

5. CXCR7 Agonist TC14012 Improves Angiogenic Function of Endothelial Progenitor Cells via Activating Akt/eNOS Pathway and Promotes Ischemic Angiogenesis in Diabetic Limb Ischemia

   • Kai Wang
   • Shiyue Sun
   • Yi Tan

   Original Article 26 April 2022 Pages: 849 - 863

   

6. Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor

   • Helmut Raphael Lieder
   • Maria Tsoumani
   • Petra Kleinbongard

   Original Article Open access 21 May 2022 Pages: 865 - 876

   

7. CircPCNX Promotes PDGF-BB-Induced Proliferation and Migration of Human Aortic Vascular Smooth Muscle Cells Through Regulating miR-1278/DNMT1 Axis

   • Wenbin Ma
   • Dongmei Wei
   • Ben Zhang

   Original Article 07 June 2022 Pages: 877 - 889

   

8. Mesenchymal Stem Cell–Originated Exosomal Lnc A2M-AS1 Alleviates Hypoxia/Reperfusion-Induced Apoptosis and Oxidative Stress in Cardiomyocytes

   • Hang Yu
   • Yuxiang Pan
   • Haibo Chen

   Original Article 11 May 2022 Pages: 891 - 904

   

9. Comparison of Evolocumab and Ezetimibe, Both Combined with Statin Therapy, for Patients with Recent Acute Coronary Syndrome: A Cost-Effectiveness Analysis from the Chinese Healthcare Perspective

   • Xiaoyu Xi
   • Xin Wang
   • Quanming Zhao

   Original Article 25 April 2022 Pages: 905 - 916

   

10. Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: an Asian Cohort Study from Singapore

    • Xin Qin Soh
    • Doreen Su-Yin Tan
    • Eric Chun Yong Chan

    Original Article 14 May 2022 Pages: 917 - 925

    

11. Effect of PCSK9 Monoclonal Antibody Versus Placebo/Ezetimibe on Atrial Fibrillation in Patients at High Cardiovascular Risk: A Meta-Analysis of 26 Randomized Controlled Trials

    • Shuai Yang
    • Wen Shen
    • Qing-Hua Wu

    Original Article 05 May 2022 Pages: 927 - 940

    

12. Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI

    • Antonio J. Vallejo-Vaz
    • Sarah Bray
    • On behalf of the DA VINCI Study Investigators

    Original Article Open access 14 May 2022 Pages: 941 - 953

    

13. The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients

    • Noha M. El-khodary
    • Asser I. Ghoneim
    • Eman M. El-touny

    Original Article Open access 10 May 2022 Pages: 955 - 964

    

14. C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study

    • Sunao Kojima
    • Kazuaki Uchiyama
    • on behalf of the Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy (FREED) investigators

    Original Article 01 June 2022 Pages: 965 - 974

    

15. Antiplatelet Therapy in End-stage Renal Disease Patients on Maintenance Dialysis: a State-of-the-art Review

    • Pietro Igor Ponchia
    • Raheel Ahmed
    • Mohammad Alkhalil

    Review Article 22 July 2022 Pages: 975 - 987

    

16. SGLT2-Inhibitors on HFpEF Patients. Role of Ejection Fraction

    • Juan Antonio Requena-Ibanez
    • Carlos G. Santos-Gallego
    • Juan J. Badimon

    Review Article 03 August 2022 Pages: 989 - 996

    

17. Mechanobiology of the endothelium in vascular health and disease: in vitro shear stress models

    • Molly L. Jackson
    • Andrew Richard Bond
    • Sarah Jane George

    Invited Review Article Open access 03 October 2022 Pages: 997 - 1010

    

18. Considerations for Left Atrial Appendage Occlusion During Cardiac Surgery

    • Christopher B. Sylvester
    • Vivek Patel
    • Gabriel Loor

    Invited Review Article 23 December 2022 Pages: 1011 - 1019

    

19. Teriflunomide treatment exacerbates cardiac ischemia reperfusion injury in isolated rat hearts

    • Emily Davis Alexander
    • Jessa L. Aldridge
    • Chad R. Frasier

    Short Communication 30 April 2022 Pages: 1021 - 1026

    

20. Long-term Dexamethasone Treatment Increases Cardiac Galectin-3 Levels

    • Senay Akin
    • Esra Gucuk-Ipek
    • Haydar A. Demirel

    Short Communication 13 May 2022 Pages: 1027 - 1029

    

21. Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial

    • Raffaele Piccolo
    • Marisa Avvedimento
    • Giovanni Esposito

    Trial Designs 20 January 2022 Pages: 1031 - 1038